{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T19:14:23Z","timestamp":1792610063800,"version":"4.5.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,9,5]],"date-time":"2022-09-05T00:00:00Z","timestamp":1662336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,9,5]],"date-time":"2022-09-05T00:00:00Z","timestamp":1662336000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Guillain\u2013Barr\u00e9 Syndrome is an immune mediated polyneuropathy. Ulcerative Colitis is an immune mediated chronic inflammatory condition mainly of the large intestine. Guillain\u2013Barr\u00e9 Syndrome can present as a rare extraintestinal manifestation of Ulcerative Colitis when in remission or in a relapse. However, the concomitant presentation of Guillain\u2013Barr\u00e9 Syndrome during a relapse of Ulcerative Colitis is very rare and only a few cases are reported to date.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>A 24\u00a0year old young male diagnosed of Ulcerative Colitis presented with bloody diarrhea of frequency more than six times a day. He had been in clinical remission even after defaulting treatment for more than a year. He had also noted difficulty in walking prior to admission to the hospital. He was managed as for a severe relapse of Ulcerative Colitis and Guillain\u2013Barr\u00e9 Syndrome. Appropriate management of both the illnesses helped him to recover.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Immune mediated diseases can have rare coexisting presentations. We report a case of Ulcerative Colitis with concomitant Guillain\u2013Barr\u00e9 Syndrome. It is essential to be open minded and timely, appropriate treatment led to successful management of both the illnesses.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12876-022-02455-y","type":"journal-article","created":{"date-parts":[[2022,9,5]],"date-time":"2022-09-05T20:37:13Z","timestamp":1662410233000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Concomitant Guillain\u2013Barr\u00e9 Syndrome in a young Sri Lankan male with severe ulcerative colitis"],"prefix":"10.1186","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0034-3105","authenticated-orcid":false,"given":"Jayasundara Mudiyanselage Hishali D","family":"Jayasundara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vajira Tharanga","family":"Samarawickrama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ranjith","family":"Peiris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tilan","family":"Aponso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danushi","family":"Abeynayake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,9,5]]},"reference":[{"issue":"3","key":"2455_CR1","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1080\/17474124.2021.1840976","volume":"15","author":"SC Wei","year":"2021","unstructured":"Wei SC, Sollano J, Hui YT, Yu W, Santos Estrella PV, Llamado LJ, Koram N. Epidemiology, burden of disease, and unmet needs in the treatment of ulcerative colitis in Asia. Expert Rev Gastroenterol Hepatol. 2021;15(3):275\u201389. https:\/\/doi.org\/10.1080\/17474124.2021.1840976.","journal-title":"Expert Rev Gastroenterol Hepatol"},{"issue":"120","key":"2455_CR2","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/B978-0-7020-4087-0.00040-1","volume":"1","author":"JM Ferro","year":"2014","unstructured":"Ferro JM, Oliveira SN, Correia L. Neurologic manifestations of inflammatory bowel diseases. Handb Clin Neurol. 2014;1(120):595\u2013605. https:\/\/doi.org\/10.1016\/B978-0-7020-4087-0.00040-1.","journal-title":"Handb Clin Neurol"},{"issue":"46","key":"2455_CR3","doi-asserted-by":"publisher","first-page":"7227","DOI":"10.3748\/wjg.v11.i46.7227","volume":"11","author":"S Danese","year":"2005","unstructured":"Danese S, Semeraro S, Papa A, Roberto I, Scaldaferri F, Fedeli G, Gasbarrini G, Gasbarrini A. Extraintestinal manifestations in inflammatory bowel disease. World J Gastroenterol. 2005;11(46):7227. https:\/\/doi.org\/10.3748\/wjg.v11.i46.7227.","journal-title":"World J Gastroenterol"},{"issue":"18","key":"2455_CR4","doi-asserted-by":"publisher","first-page":"2333","DOI":"10.2165\/11638120-000000000-00000","volume":"72","author":"G Trikudanathan","year":"2012","unstructured":"Trikudanathan G, Venkatesh PG, Navaneethan U. Diagnosis and therapeutic management of extra-intestinal manifestations of inflammatory bowel disease. Drugs. 2012;72(18):2333\u201349. https:\/\/doi.org\/10.2165\/11638120-000000000-00000.","journal-title":"Drugs"},{"issue":"4","key":"2455_CR5","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1097\/00004836-198508000-00006","volume":"7","author":"J Zimmerman","year":"1985","unstructured":"Zimmerman J, Steiner I, Gavish D, Argov Z. Guillain\u2013Barr\u00e9 syndrome: a possible extraintestinal manifestation of ulcerative colitis. J Clin Gastroenterol. 1985;7(4):301\u20133. https:\/\/doi.org\/10.1097\/00004836-198508000-00006.","journal-title":"J Clin Gastroenterol"},{"key":"2455_CR6","unstructured":"Malik TF, Aurelio DM. Extraintestinal Manifestations of Inflammatory Bowel Disease. PMID: 33760556"},{"key":"2455_CR7","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/S0300-2977(98)00147-8","volume":"54","author":"B Roca","year":"1999","unstructured":"Roca B, Moreno I, Meneu E, et al. Ulcerative colitis and acquired demyelinating neuropathy (Guillain\u2013Barr\u00e9 syndrome). Neth J Med. 1999;54:129\u201330.","journal-title":"Neth J Med"},{"issue":"3","key":"2455_CR8","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1212\/WNL.45.3.416","volume":"45","author":"A Lossos","year":"1995","unstructured":"Lossos A, River Y, Eliakim A, Steiner I. Neurologic aspects of inflammatory bowel disease. Neurology. 1995;45(3):416\u201321. https:\/\/doi.org\/10.1212\/WNL.45.3.416.","journal-title":"Neurology"},{"issue":"1","key":"2455_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1755-7682-3-15","volume":"3","author":"RG de la Torre","year":"2010","unstructured":"de la Torre RG, Mor\u00eds G, Mart\u00ednez DP, Montes IC. Guillain\u2013Barr\u00e9 syndrome, tuberculosis and inflammatory bowel disease: a multiple association. Int Arch Med. 2010;3(1):1\u20134. https:\/\/doi.org\/10.1186\/1755-7682-3-15.","journal-title":"Int Arch Med"},{"key":"2455_CR10","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1002\/ibd.21071","volume":"16","author":"CS Krystallis","year":"2010","unstructured":"Krystallis CS, Kamberoglou DK, Cheilakos GB, et al. Guillain-Barr\u00e9 syndrome during a relapse of ulcerative colitis: a case report. Inflamm Bowel Dis. 2010;16:555\u20136. https:\/\/doi.org\/10.1002\/ibd.21071.","journal-title":"Inflamm Bowel Dis"},{"key":"2455_CR11","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000011013","author":"Z Liu","year":"2018","unstructured":"Liu Z, Zhou K, Tian S, Dong W. Ulcerative colitis with Guillain\u2013Barr\u00e9 syndrome: a case report. Medicine. 2018. https:\/\/doi.org\/10.1097\/MD.0000000000011013.","journal-title":"Medicine"},{"issue":"11","key":"2455_CR12","first-page":"1121","volume":"34","author":"M Saito","year":"1994","unstructured":"Saito M, Hozumi I, Kawakami A, Tsuji S. A case of post-rubella Guillain-Barre syndrome associated with ulcerative colitis. Rinsho shinkeigaku Clin Neurol. 1994;34(11):1121\u20134 (PMID: 7729092).","journal-title":"Rinsho shinkeigaku Clin Neurol"},{"issue":"3","key":"2455_CR13","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/s12328-019-00939-1","volume":"12","author":"K Tominaga","year":"2019","unstructured":"Tominaga K, Tsuchiya A, Sato H, Kimura A, Oda C, Hosaka K, Kawata Y, Kimura N, Hayashi K, Yokoyama J, Terai S. Co-existent ulcerative colitis and Guillain-Barr\u00e9 syndrome: a case report and literature review. Clin J Gastroenterol. 2019;12(3):243\u20136. https:\/\/doi.org\/10.1007\/s12328-019-00939-1.","journal-title":"Clin J Gastroenterol"},{"issue":"4","key":"2455_CR14","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1002\/ana.410400414","volume":"40","author":"C Hafer-Macko","year":"1996","unstructured":"Hafer-Macko C, Hsieh ST, Ho TW, Sheikh K, Cornblath DR, Li CY, McKhann GM, Asbury AK, Grffin JW. Acute motor axonal neuropathy: an antibody-mediated attack on axolemma. Ann Neurol Off J Am Neurol Assoc Child Neurol Soc. 1996;40(4):635\u201344. https:\/\/doi.org\/10.1002\/ana.410400414.","journal-title":"Ann Neurol Off J Am Neurol Assoc Child Neurol Soc"},{"key":"2455_CR15","doi-asserted-by":"publisher","first-page":"S650","DOI":"10.14309\/00000434-201210001-01609","volume":"107","author":"M Paquin-Gobeil","year":"2012","unstructured":"Paquin-Gobeil M, Hassard P, Gupta G. Guillain\u2013Barre syndrome in ulcerative colitis following treatment with infliximab: 1609. Off J Am College Gastroenterol ACG. 2012;107:S650.","journal-title":"Off J Am College Gastroenterol ACG."},{"issue":"4","key":"2455_CR16","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1136\/ard.2005.043208","volume":"67","author":"S Silburn","year":"2008","unstructured":"Silburn S, McIvor E, McEntegart A, Wilson H. Guillain\u2013Barr\u00e9 syndrome in a patient receiving anti-tumour necrosis factor [alpha] for rheumatoid arthritis: a case report and discussion of literature. Ann Rheum Dis. 2008;67(4):575. https:\/\/doi.org\/10.1136\/ard.2005.043208.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"2455_CR17","doi-asserted-by":"publisher","first-page":"18","DOI":"10.5009\/gnl14226","volume":"9","author":"SC Park","year":"2015","unstructured":"Park SC, Jeen YT. Current and emerging biologics for ulcerative colitis. Gut Liver. 2015;9(1):18.","journal-title":"Gut Liver"},{"issue":"4","key":"2455_CR18","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1080\/14712598.2020.1727437","volume":"20","author":"G Fiorino","year":"2020","unstructured":"Fiorino G, Allocca M, Correale C, Roda G, Furfaro F, Loy L, Zilli A, Peyrin-Biroulet L, Danese S. Positioning ustekinumab in moderate-to-severe ulcerative colitis: new kid on the block. Expert Opin Biol Ther. 2020;20(4):421\u20137.","journal-title":"Expert Opin Biol Ther"},{"key":"2455_CR19","doi-asserted-by":"publisher","first-page":"1759720X2097777","DOI":"10.1177\/1759720X20977777","volume":"13","author":"MS Chimenti","year":"2021","unstructured":"Chimenti MS, Conigliaro P, Biancone L, Perricone R. Update on the therapeutic management of patients with either psoriatic arthritis or ulcerative colitis: focus on the JAK inhibitor tofacitinib. Ther Adv Musculoskelet Dis. 2021;13:1759720X20977777. https:\/\/doi.org\/10.1177\/1759720X20977777.","journal-title":"Ther Adv Musculoskelet Dis"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-022-02455-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-022-02455-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-022-02455-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,5]],"date-time":"2022-09-05T20:39:17Z","timestamp":1662410357000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgastroenterol.biomedcentral.com\/articles\/10.1186\/s12876-022-02455-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,5]]},"references-count":19,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["2455"],"URL":"https:\/\/doi.org\/10.1186\/s12876-022-02455-y","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,5]]},"assertion":[{"value":"21 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Informed written consent for the publication of details and pictures was obtained from the patient. Consent form can be made available to the editor on request.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"411"}}